DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Osiris Therapeutics, Inc.

NASDAQ: OSIR

+ Add to Portfolio

company name or ticker

Osiris - Can Stem Cells Lead To Profits?

6/17/2013 by Seeking Alpha

Penny-Wise, Pound-Foolish Stem Cell Stocks

6/14/2013 by Seeking Alpha

Osiris Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference

5/30/2013 by DailyFinance

Pipeline Progress at Gilead - Analyst Blog

5/16/2013 by Zacks

Is the Golden Age of Blockbusters Over?

Big Pharma enjoyed a pretty historic run in the last two decades. But with the patent cliff stifling industry growth, is the Golden Age of the Blockbuster over for good? This one might be, but investors cannot rule out future opportunities.
5/8/2013 by DailyFinance

Osiris Loss In-Line with Expectations - Analyst Blog

5/8/2013 by Zacks

Osiris Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript

5/7/2013 by Seeking Alpha

Osiris CEO: Our Stem Cell Drug With Zero Sales Is Widely Used

5/7/2013 by TheStreet

Osiris Therapeutics Announces First Quarter 2013 Financial Results

5/7/2013 by DailyFinance

Loss at Aegerion Narrower Than Expected - Analyst Blog

5/3/2013 by Zacks
See More Articles...